CAS No. |
263251-78-1 |
|---|---|
中文名称 |
他维拉米德 |
英文名称 |
Tavilermide |
别名 |
Tavilermide;3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1,5,8,11]oxatriazacyclotetradecin-10-yl)propanoic acid(WXG02263);Glycine, N-(2-hydroxy-5-nitrobenzoyl)-L-α-glutamyl-L-lysyl-L-homoseryl-, cyclic (1→3)-ether;3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1,5,8,11]oxatriazacyclotetradecin-10-yl)propanoic acid;MIM-D3 |
标准英文名 |
3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1]oxa[5,8,11]triazacyclotetradecin-10-yl)propanoic acid |
分子式 |
C24H32N6O11 |
分子量 |
580.55 |
精确分子量 |
580.21 |
SMILES |
O=C1C2=CC([N+]([O-])=O)=CC=C2OCC[C@@]([H])(C(NCC(O)=O)=O)NC([C@@H](NC([C@@H](N1)CCC(O)=O)=O)CCCCN)=O |
标准SMILES |
NCCCC[C@@H]1NC(=O)[C@H](CCC(O)=O)NC(=O)C2=CC(=CC=C2OCC[C@H](NC1=O)C(=O)NCC(O)=O)[N+]([O-])=O |
用途 |
Tavilermide is a selective TrkA partial agonist used for the treatment of dry eye; it mimics the activities of NGF without binding to the p75NTR receptor and can potentiate the effects of suboptimal concentrations of NGF. |
InChIKey |
DVJXNXPFYJIACK-ULQDDVLXSA-N |
|
|
评论 |
|---|